未来健康弃A转港：SKG按摩仪增长见顶、明星代言难掩研发乏力 创始人夫妇累计分红超5亿

Core Viewpoint - Future Health, the parent company of the SKG massage device brand, has submitted an application for a mainboard listing on the Hong Kong Stock Exchange after a tumultuous IPO journey in China [1][15]. Financial Performance - Future Health reported total revenues of 9.05 billion yuan, 10.46 billion yuan, and 10.45 billion yuan for the years 2022, 2023, and 2024 respectively, with adjusted net profits of 1.37 billion yuan, 1.23 billion yuan, and 1.26 billion yuan, maintaining a gross margin around 50% [1][15]. - For the first three quarters of 2025, the company achieved approximately 8.78 billion yuan in total revenue, a year-on-year increase of 16.2%, and an adjusted net profit of about 1.18 billion yuan, a significant increase of 58.8% compared to the same period in 2024 [2][16]. Product Performance - The sales of the core product, the SKG neck massage device, have stagnated, with sales volume fluctuating and showing a slight increase of 3.2% in the first three quarters of 2025, but revenue from this product category decreased by 1.8% [3][20]. - Other products, such as the eye and waist massage devices, have not developed as expected, with sales declining by 16.8% and 0.8% respectively in the first nine months of 2025 [5][20]. Marketing and R&D - Future Health has heavily invested in marketing, with sales and marketing expenses rising from 1.64 billion yuan in 2022 to 1.98 billion yuan in 2025, while R&D expenses have decreased, leading to a lower R&D expense ratio from 9.1% to 6.6% [7][22]. - The company has relied on celebrity endorsements for marketing, with significant spending on endorsements, which accounted for about 10% of sales and marketing expenses in 2021-2022 [6][21]. Customer Concentration and Financial Health - Future Health's revenue is highly concentrated, with the top five customers contributing over 40% of total revenue, which poses risks to the company's financial stability [11][24]. - The company has been generous with cash dividends, distributing a total of 5.94 billion yuan from 2020 to 2023, while also increasing its bank borrowings by 176.8% to 1.80 billion yuan as of September 30, 2025, raising concerns about its financial management [12][28].